Immunomedics Extends Patent Life on Therapeutic Antibodies

[GlobeNewswire] – MORRIS PLAINS, N.J. — Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other … more

View todays social media effects on IMMU

View the latest stocks trending across Twitter. Click to view dashboard

See who Immunomedics is hiring next, click here to view